The flow cytometric analysis shows that T cells persistently activated by tumor antigens using this protocol displayed a progressive increase in CD45RO−CD62L− effector T cell (Teff) and CD45RO+CD62L− effector memory T cell (Tem) populations. The gene discussed is SELL; the disease is neoplasm.